Development and validation of a liquid chromatography tandem mass spectrometry method for the determination of cannabinoids and phase I and II metabolites in meconium
- 1 May 2017
- journal article
- Published by Elsevier in Journal of Chromatography A
- Vol. 1497, 118-126
Abstract
No abstract availableKeywords
Funding Information
- Plan Nacional de Drogas, Ministerio de Sanidad, Gobierno de España
This publication has 23 references indexed in Scilit:
- Effect of hydrolysis on identifying prenatal cannabis exposureAnalytical and Bioanalytical Chemistry, 2010
- Correlations of Maternal Buprenorphine Dose, Buprenorphine, and Metabolite Concentrations in Meconium With Neonatal OutcomesClinical Pharmacology & Therapeutics, 2008
- Biological Matrices for the Evaluation of In Utero Exposure to Drugs of AbuseTherapeutic Drug Monitoring, 2007
- Prevalence of gestational exposure to cannabis in a Mediterranean city by meconium analysisActa Paediatrica, 2007
- Confirmation of cannabinoids in meconium using two-dimensional gas chromatography with mass spectrometry detectionJournal of Chromatography B, 2007
- Bioanalytical procedures for monitoring in utero drug exposureAnalytical and Bioanalytical Chemistry, 2007
- Quantification of Δ9-tetrahydrocannabinol and its Major Metabolites in Meconium by Gas Chromatographic-mass Spectrometric Assay: Assay Validation and Preliminary Results of the “Meconium Project”Therapeutic Drug Monitoring, 2006
- Marijuana impairs growth in mid-gestation fetusesNeurotoxicology and Teratology, 2005
- Maternal use of cannabis and pregnancy outcomeBJOG: An International Journal of Obstetrics & Gynaecology, 2002
- Effects of Marijuana Use during Pregnancy on Newborn CryChild Development, 1989